Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
October 04, 2022
Most R&D money flows from the private sector, which aims to maximize returns on investment. As a result, health R&D largely skews towards rich countries’ priorities and health system technical capacities, leaving significant gaps in diseases that primarily affect poor and marginalized populations.
POLICY PAPERS
October 04, 2022
In this paper, we report the results of a horizon-scanning exercise to source opportunities for global health R&D investment—that is, high-value potential biomedical innovations which are currently underfunded but which could be transformative for health, quality of life, and health security in LMIC...
Blog Post
August 04, 2022
At the July G20 meeting of finance ministers and central bank governors, a panel of experts (of which I was one) presented their report on the capital adequacy of the MDBs. Why care? the answer, quite simply, is that hundreds of billions of dollars are at stake. As with any bank, small changes in th...
Blog Post
June 28, 2022
CGD has set up a working group to examine different ways to purchase antimicrobials in LMICs in order to identify actionable policies to improve access and stewardship for key products and increase funding for research into new ones. We are launching today the Working Group’s first working paper.
CGD NOTES
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.
Blog Post
April 28, 2022
The idea that shavings of public gold sprinkled like fairy dust on private investment projects would bring to life a giant array of infrastructure and services which in turn would gift us wondrous progress in development hasn’t worked out. It is time to drop the fantasy and focus instead on the test...
Blog Post
April 20, 2022
In 2021, Ghana announced a plan to issue sovereign bonds of up to $2 billion, with proceeds due partially to fund a free secondary school program. Just months later, Ghana’s rising debt burden means this is no longer feasible. Can developing countries tap the social bond market in order to fund publ...
Blog Post
April 13, 2022
Tuberculosis, once highly prevalent across Europe and North America, has largely been forgotten in the West but remains a heavy burden in low- and middle-income countries. Now, as rich countries vaccinate (and boost) their populations against COVID-19, lift restrictions, and slowly return to “normal...
CGD NOTES
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...